Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Characterization of mammary-specific disruptions for Tph1 and Lrp5 during murine lactation.

Weaver SR, Jury NJ, Gregerson KA, Horseman ND, Hernandez LL.

Sci Rep. 2017 Nov 9;7(1):15155. doi: 10.1038/s41598-017-15508-0.

2.

Mammary Development and Breast Cancer: A Wnt Perspective.

Yu QC, Verheyen EM, Zeng YA.

Cancers (Basel). 2016 Jul 13;8(7). pii: E65. doi: 10.3390/cancers8070065. Review.

3.

Downregulation of human Wnt3 in gastric cancer suppresses cell proliferation and induces apoptosis.

Wang HS, Nie X, Wu RB, Yuan HW, Ma YH, Liu XL, Zhang JY, Deng XL, Na Q, Jin HY, Bian YC, Gao YM, Wang YD, Chen WD.

Onco Targets Ther. 2016 Jun 27;9:3849-60. doi: 10.2147/OTT.S101782. eCollection 2016.

4.

Cooperative antiproliferative signaling by aspirin and indole-3-carbinol targets microphthalmia-associated transcription factor gene expression and promoter activity in human melanoma cells.

Poindexter KM, Matthew S, Aronchik I, Firestone GL.

Cell Biol Toxicol. 2016 Apr;32(2):103-19. doi: 10.1007/s10565-016-9321-5. Epub 2016 Apr 7.

5.

Lrp5 Has a Wnt-Independent Role in Glucose Uptake and Growth for Mammary Epithelial Cells.

Chin EN, Martin JA, Kim S, Fakhraldeen SA, Alexander CM.

Mol Cell Biol. 2015 Dec 28;36(6):871-85. doi: 10.1128/MCB.00800-15.

6.

Targeting the WNT Signaling Pathway in Cancer Therapeutics.

Tai D, Wells K, Arcaroli J, Vanderbilt C, Aisner DL, Messersmith WA, Lieu CH.

Oncologist. 2015 Oct;20(10):1189-98. doi: 10.1634/theoncologist.2015-0057. Epub 2015 Aug 25. Review.

7.

Candidate colorectal cancer predisposing gene variants in Chinese early-onset and familial cases.

Zhang JX, Fu L, de Voer RM, Hahn MM, Jin P, Lv CX, Verwiel ET, Ligtenberg MJ, Hoogerbrugge N, Kuiper RP, Sheng JQ, Geurts van Kessel A.

World J Gastroenterol. 2015 Apr 14;21(14):4136-49. doi: 10.3748/wjg.v21.i14.4136.

8.

Ligand-independent canonical Wnt activity in canine mammary tumor cell lines associated with aberrant LEF1 expression.

Gracanin A, Timmermans-Sprang EP, van Wolferen ME, Rao NA, Grizelj J, Vince S, Hellmen E, Mol JA.

PLoS One. 2014 Jun 2;9(6):e98698. doi: 10.1371/journal.pone.0098698. eCollection 2014.

9.

Ductal barriers in mammary epithelium.

Owens MB, Hill AD, Hopkins AM.

Tissue Barriers. 2013 Oct 1;1(4):e25933. doi: 10.4161/tisb.25933. Epub 2013 Aug 9. Review.

10.

The way Wnt works: components and mechanism.

Saito-Diaz K, Chen TW, Wang X, Thorne CA, Wallace HA, Page-McCaw A, Lee E.

Growth Factors. 2013 Feb;31(1):1-31. doi: 10.3109/08977194.2012.752737. Epub 2012 Dec 21. Review.

11.

LRP5 and LRP6 in development and disease.

Joiner DM, Ke J, Zhong Z, Xu HE, Williams BO.

Trends Endocrinol Metab. 2013 Jan;24(1):31-9. doi: 10.1016/j.tem.2012.10.003. Review.

12.

WNT10A plays an oncogenic role in renal cell carcinoma by activating WNT/β-catenin pathway.

Hsu RJ, Ho JY, Cha TL, Yu DS, Wu CL, Huang WP, Chu P, Chen YH, Chen JT, Yu CP.

PLoS One. 2012;7(10):e47649. doi: 10.1371/journal.pone.0047649. Epub 2012 Oct 19.

13.

Frizzled homolog proteins, microRNAs and Wnt signaling in cancer.

Ueno K, Hirata H, Hinoda Y, Dahiya R.

Int J Cancer. 2013 Apr 15;132(8):1731-40. doi: 10.1002/ijc.27746. Epub 2012 Aug 30. Review.

14.

Wnt signaling in mammary glands: plastic cell fates and combinatorial signaling.

Alexander CM, Goel S, Fakhraldeen SA, Kim S.

Cold Spring Harb Perspect Biol. 2012 Oct 1;4(10). pii: a008037. doi: 10.1101/cshperspect.a008037. Review.

15.

Drugging Wnt signalling in cancer.

Polakis P.

EMBO J. 2012 Jun 13;31(12):2737-46. doi: 10.1038/emboj.2012.126. Epub 2012 May 22. Review. Erratum in: EMBO J. 2012 Aug;31(15):3375.

16.

Upregulation of the Wnt co-receptor LRP6 promotes hepatocarcinogenesis and enhances cell invasion.

Tung EK, Wong BY, Yau TO, Ng IO.

PLoS One. 2012;7(5):e36565. doi: 10.1371/journal.pone.0036565. Epub 2012 May 3.

17.

Wnt signaling in cancer.

Polakis P.

Cold Spring Harb Perspect Biol. 2012 May 1;4(5). pii: a008052. doi: 10.1101/cshperspect.a008052. Review.

18.

Both LRP5 and LRP6 receptors are required to respond to physiological Wnt ligands in mammary epithelial cells and fibroblasts.

Goel S, Chin EN, Fakhraldeen SA, Berry SM, Beebe DJ, Alexander CM.

J Biol Chem. 2012 May 11;287(20):16454-66. doi: 10.1074/jbc.M112.362137. Epub 2012 Mar 20.

19.

A systematic screen for micro-RNAs regulating the canonical Wnt pathway.

Anton R, Chatterjee SS, Simundza J, Cowin P, Dasgupta R.

PLoS One. 2011;6(10):e26257. doi: 10.1371/journal.pone.0026257. Epub 2011 Oct 17.

20.

Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells.

Lu D, Choi MY, Yu J, Castro JE, Kipps TJ, Carson DA.

Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13253-7. doi: 10.1073/pnas.1110431108. Epub 2011 Jul 25.

Supplemental Content

Support Center